3 results
Approved WMOCompleted
The aim of this prospective, multicentre randomized phase II study is to evaluate the safety and efficacy of the combination of capmatinib and spartalizumab in subjects with EGFR weight (for exon 19 deletions and exon 21 L858R substitution mutations…
Approved WMOWill not start
The objective of this study is to assess the safety and feasibility of the Doraya Catheter in the treatment of subjects hospitalized with congestive AHF, with insufficient response to diuretic therapy.
Approved WMOCompleted
To evaluate the efficacy of each combination arm, as measured by confirmed objective response rate (ORR)